- Article
Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy
- Mengen Zhang,
- Jingyi Zhu,
- Yun Zheng,
- Rui Guo,
- Shige Wang,
- Serge Mignani,
- Anne-Marie Caminade,
- Jean-Pierre Majoral and
- Xiangyang Shi
We present here the development of multifunctional doxorubicin (DOX)-conjugated poly(amidoamine) (PAMAM) dendrimers as a unique platform for pH-responsive drug release and targeted chemotherapy of cancer cells. In this work, we covalently conjugated...

